Health Canada has given Moderna the green light to launch a clinical trial for a vaccine targeting the Bundibugyo form of the Ebola virus, which continues to surge throughout the Democratic Republic ...
Merck and Moderna report that a personalized mRNA vaccine helped prevent skin cancer from returning in high-risk patients.